SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-22-000022
Filing Date
2022-07-11
Accepted
2022-07-11 08:14:04
Documents
13
Period of Report
2022-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20220709.htm   iXBRL 8-K 38075
2 EX-99.1 ex991_pressreleasejuly1120.htm EX-99.1 17741
  Complete submission text file 0000875320-22-000022.txt   199534

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20220709.xsd EX-101.SCH 1993
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20220709_lab.xml EX-101.LAB 24229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20220709_pre.xml EX-101.PRE 12685
7 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20220709_htm.xml XML 10658
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 221075907
SIC: 2834 Pharmaceutical Preparations